Literature DB >> 33211836

RUNX1 and inv(16) are frenemies in AML.

Sridhar Rao1.   

Abstract

Entities:  

Year:  2020        PMID： 33211836      PMCID： PMC7685212          DOI： 10.1182/blood.2020008802

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Hematologic malignancies.

Authors:  D G Gilliland
Journal:  Curr Opin Hematol       Date:  2001-07       Impact factor: 3.284

2.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

3.  The genomic landscape of core-binding factor acute myeloid leukemias.

Authors:  Zachary J Faber; Xiang Chen; Amanda Larson Gedman; Kristy Boggs; Jinjun Cheng; Jing Ma; Ina Radtke; Jyh-Rong Chao; Michael P Walsh; Guangchun Song; Anna K Andersson; Jinjun Dang; Li Dong; Yu Liu; Robert Huether; Zhongling Cai; Heather Mulder; Gang Wu; Michael Edmonson; Michael Rusch; Chunxu Qu; Yongjin Li; Bhavin Vadodaria; Jianmin Wang; Erin Hedlund; Xueyuan Cao; Donald Yergeau; Joy Nakitandwe; Stanley B Pounds; Sheila Shurtleff; Robert S Fulton; Lucinda L Fulton; John Easton; Evan Parganas; Ching-Hon Pui; Jeffrey E Rubnitz; Li Ding; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Charles G Mullighan; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Lars Bullinger; Jinghui Zhang; Jeffery M Klco; James R Downing
Journal:  Nat Genet       Date:  2016-10-31       Impact factor: 38.330

4.  Comprehensive mutational profiling of core binding factor acute myeloid leukemia.

Authors:  Nicolas Duployez; Alice Marceau-Renaut; Nicolas Boissel; Arnaud Petit; Maxime Bucci; Sandrine Geffroy; Hélène Lapillonne; Aline Renneville; Christine Ragu; Martin Figeac; Karine Celli-Lebras; Catherine Lacombe; Jean-Baptiste Micol; Omar Abdel-Wahab; Pascale Cornillet; Norbert Ifrah; Hervé Dombret; Guy Leverger; Eric Jourdan; Claude Preudhomme
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 5.  Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.

Authors:  Susumu Goyama; James C Mulloy
Journal:  Int J Hematol       Date:  2011-05-03       Impact factor: 2.490

6.  Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice.

Authors:  Anuradha Illendula; John A Pulikkan; Hongliang Zong; Jolanta Grembecka; Liting Xue; Siddhartha Sen; Yunpeng Zhou; Adam Boulton; Aravinda Kuntimaddi; Yan Gao; Roger A Rajewski; Monica L Guzman; Lucio H Castilla; John H Bushweller
Journal:  Science       Date:  2015-02-13       Impact factor: 47.728

7.  The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.

Authors:  Claudia Schoch; Wolfgang Kern; Susanne Schnittger; Thomas Büchner; Wolfgang Hiddemann; Torsten Haferlach
Journal:  Haematologica       Date:  2004-09       Impact factor: 9.941

8.  RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.

Authors:  Tao Zhen; Yaqiang Cao; Gang Ren; Ling Zhao; R Katherine Hyde; Guadalupe Lopez; Dechun Feng; Lemlem Alemu; Keji Zhao; P Paul Liu
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

9.  The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.

Authors:  N Adya; T Stacy; N A Speck; P P Liu
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

Authors:  Ya-Huei Kuo; Sean F Landrette; Susan A Heilman; Paola N Perrat; Lisa Garrett; Pu P Liu; Michelle M Le Beau; Scott C Kogan; Lucio H Castilla
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 38.585
  10 in total
  1 in total

Review 1.  Emerging therapies for inv(16) AML.

Authors:  Sridevi Surapally; Daniel G Tenen; John A Pulikkan
Journal:  Blood       Date:  2021-05-13       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.